Hodgkin's lymphoma in a patient treated for Wegener's granulomatosis with cyclophosphamide and azathioprine
Colburn, K.K.; Cao, J.D.; Krick, E.H.; Mortensen, S.E.; Wong, L.G.
Journal of Rheumatology 12(3): 599-602
1985
ISSN/ISBN: 0315-162X PMID: 4045860 Document Number: 251161
Only 5 neoplasms have been reported associated with the use of cytotoxic drugs in the treatment of Wegener's granulomatosis. Described here for the first time, to our knowledge, is a patient with Wegener's granulomatosis treated with cyclophosphamide and azathioprine who later developed Hodgkin's lymphoma.
Document emailed within 1 workday
Related Documents
Szmurło-Zabolicka, B. 1988: Wegener's granulomatosis or Hodgkin's disease--diagnostic error or one of the forms of Wegener's granulomatosis? Polski Tygodnik Lekarski 43(33): 1072Bir, K.; Herzenberg, A.M.; Carette, S. 2006: Azathioprine induced acute interstitial nephritis as the cause of rapidly progressive renal failure in a patient with Wegener's granulomatosis Journal of Rheumatology 33(1): 185-187
Kovacević, Z.; Mitrović, D.; Tomić, I.; Jovanović, D.; Skatarić, V.; Dimitrijević, J.; Rabrenović, V.; Trifunović, G. 1999: Pulsed doses of cyclophosphamide in the treatment of Wegener's granulomatosis Vojnosanitetski Pregled 56(1): 31-37
Baliga, R.; Chang, C.H.; Bidani, A.K.; Perrin, E.V.; Fleischmann, L.E. 1978: A case of generalized Wegener's granulomatosis in childhood: successful therapy with cyclophosphamide Pediatrics 61(2): 286-290
Chapman, P.T.; O'Donnell, J.L. 1993: Respiratory failure in Wegener's granulomatosis: response to pulse intravenous methylprednisolone and cyclophosphamide Journal of Rheumatology 20(3): 504-506
Lovelace, K.; Cannon, T.C.; Flynn, S.; Davis, P.; Schmucker, T.; Westfall, C.T. 2004: Optic neuropathy in patient with Wegener's granulomatosis Journal of the Arkansas Medical Society 100(12): 428-429
Gurevich, M.A.; Tukhmanova, L.G. 1973: Myocardial infarct in a patient with Wegener's granulomatosis Kardiologiia 13(2): 124-127
Santini, G.; Coser, P.; Congiu, A.M.; Salvagno, L.; De Souza, C.; Sertoli, M.R.; Olivieri, A.; Chisesi, T.; Rubagotti, A.; Truini, M.; Contu, A.; Porcellini, A.; Zambaldi, G.; Nati, S.; Marino, G.; Rizzoli, V. 2000: VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group Haematologica 85(2): 160-166
Sturrock, R.D.; Ratnesar, P. 1974: Wegener's granulomatosis occurring in a patient with pre-existing rheumatoid arthritis British Journal of Clinical Practice 28(5): 183-184
Kara, M.; Tiftik, T.ül.; Kaya, A.; Sarı, F.; Özel, S.; Özçakar, L. 2014: Ultrasonographic imaging of the peripheral nerves in a Wegener granulomatosis patient with multiple mononeuropathies Acta Reumatologica Portuguesa 39(1): 96-97
Mena, C.; Kiat-amnuay, S.; Chua, S.; Hasapes, J.; Vigneswaran, N. 2016: Oral and Maxillofacial Pathology. Case of the Month. Limited granulomatosis with polyangiitis (Wegener's granulomatosis) Texas Dental Journal 133(1): 14-5 52-4
Boudes, P.; Andre, C.; Belghiti, D.; Sobel, A. 1990: Microscopic Wegener's disease: a particular form of Wegener's granulomatosis Journal of Rheumatology 17(10): 1412-1414
Bosch, X.; Forns, X.; Font, J.; Mirapeix, E.; Revert, L.; Ingelmo, M. 1991: Neutrophil anticytoplasmic antibodies in a patient with Wegener's granulomatosis: therapeutic implications of its detection and relation to clinical activity Medicina Clinica 97(20): 780-782
Durant, J.R.; Gams, R.A.; Bartolucci, A.A.; Dorfman, R.F. 1977: BCNU with and without cyclophosphamide, vincristine, and prednisone (COP) and cycle-active therapy in non-Hodgkin's lymphoma Cancer Treatment Reports 61(6): 1085-1096
Izumi, T.; Muroi, K.; Hoshino, Y.; Komatsu, N.; Ohtsuki, T.; Yamada, M.; Tomizuka, H.; Hatake, K.; Furusawa, S.; Miura, Y. 1996: Biweekly cyclophosphamide, epirubicin, vincristine and prednisolone (CEOP) chemotherapy for the elderly patients with aggressive non-Hodgkin's lymphoma. Tochigi Malignant Lymphoma Study Group for the Elderly Patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(6): 797-800
Montalban, C.; Bellas, C.; Rodriguez-Garcia, J.L.; Aguado, M.; Fernandez-Muñoz, R. 1991: Non-Hodgkin's lymphoma after prolonged remission of Hodgkin's disease in an HIV-infected patient Annals of Oncology: Official Journal of the European Society for Medical Oncology 2(8): 585-587
Bucerius, J.; Herkel, C.; Joe, A.Y.; Altehoefer, C.; Finke, J.; Moser, E.; Reinhardt, M.J. 2006: (18)F-FDG PET and conventional imaging for assessment of Hodgkin's disease and non Hodgkin's lymphoma. An analysis of 193 patient studies Nuklearmedizin. Nuclear medicine 45(3): 105-10; quiz N25-6
Abdallah, M.; Saleh, M.; Elgouhari, H.; Huntington, M.K. 2019: Development of Leiomyosarcoma in a Patient Treated with Azathioprine South Dakota Medicine: the Journal of the South Dakota State Medical Association 72(5): 214-216
Behringer, K.; Wildt, L.; Mueller, H.; Mattle, V.; Ganitis, P.; van den Hoonaard, B.; Ott, H.W.; Hofer, S.; Pluetschow, A.; Diehl, V.; Engert, A.; Borchmann, P. 2010: No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase Ii trial from the German Hodgkin Study Group Annals of Oncology: Official Journal of the European Society for Medical Oncology 21(10): 2052-2060
Merli, F.; Federico, M.; Avanzini, P.; Ilariucci, F.; Stelitano, C.; Iannitto, E.; Colombi, M.; Vallisa, D.; Santagati, G.; Picinini, L. 1998: Weekly administration of vincristine, cyclophosphamide, mitoxantrone and bleomycin (VEMB) in the treatment of elderly aggressive non Hodgkin's lymphoma. Gruppo Italiano per lo Studio dei Linfomi Haematologica 83(3): 217-221